MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

    P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)

    Objective: to investigate cerebral glucose metabolism via fluorodeoxyglucose positron emission tomography (FDG-PET) and its correlation to clinical features in Parkinson’s disease (PD) patients with GBA1…
  • 2025 International Congress

    Parkinsonism following Chronic Disulfiram Overdose

    S. Ray, V. Kamath, B. Bairy (Bangalore, India)

    Objective: To describe the effect of chronic intake of disulfiram Background: Background- Drug induced parkinsonism is one of the commonest causes of non-degenerative parkinsonism. Typical…
  • 2025 International Congress

    Gait Characteristics and Cognitive status correlation during Dual-Task Walking in Elderly Subjects of Different Age

    S. Radovanovic, V. Markovic, N. Nedovic (Belgrade, Serbia)

    Objective: Gait characteristics relationships to cognitive status were estimated by measuring gait performance and tested cognitive status and cognitive functions in three groups of healthy…
  • 2025 International Congress

    Baseline brain inflammation is associated with less cognitive progression at 24 months in subjects with de novo Parkinson’s disease

    T. Yacoubian, N. Stover, M. Dean, A. Amara, L. Ruffrage, H. Qin, E. Benveniste, Y. Fang, J. Mcconathy, Y. Zhang, R. Kennedy, A. Gerstenecker, D. Standaert (Birmingham, USA)

    Objective: To examine if brain inflammation measured by 18F-DPA-714 imaging is associated with cognitive change in subjects with early Parkinson’s disease (PD). Background: Evidence for…
  • 2025 International Congress

    Positive post-intervention effect of Biodanza therapy on inhibitory control related to the orbitomedial prefrontal cortex.

    M. Moreno, M. Aveiga, J. Guapisaca, G. Bueno, M. Pinos (CUENCA, Ecuador)

    Objective: A study was conducted to determine the effect of a Music-based-Movement (MbM) program on the physical and cognitive domains of a group of people…
  • 2025 International Congress

    Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

    R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)

    Objective: ​​​​​To compare 3 scales which have been used in literature to determine subjective cognitive complaints (SCC) in Parkinson’s disease (PD) and explore their relationship…
  • 2025 International Congress

    Single-Center Real-World Validation of Cognitive vs. Motor-Based Fall Prediction Models in Parkinson’s Disease

    S. Anis, E. Zimmerman, H. Fernandez, A. Rosenfeldt, J. Alberts (Cleveland, USA)

    Objective: This study aimed to evaluate the performance of our previously developed cognitive-based fall prediction model (Anis et al. 2025) in a real-world setting using…
  • 2025 International Congress

    Cholinergic activity associates with cognitive function in PD using [18F]VAT

    J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To map the relationship between cholinergic activity in Parkinson Disease (PD) and cognitive performance and identify any differences in this relationship in cognitive impairment.…
  • 2025 International Congress

    Efficacy of Stimulant Use for Cognitive Fluctuations in Lewy Body Dementia: A Case Study

    L. Lopez, A. Petrov, Z. Afshari (Glenview, USA)

    Objective: To evaluate the effectiveness of stimulants in reducing cognitive fluctuations in Lewy Body Dementia (LBD). Background: Lewy Body Dementia (LBD) is the 2nd most…
  • 2025 International Congress

    Sensitivity to Reward and Decision-Making in Functional Motor Disorder: a Case-Control Study

    V. Nistico', B. Gonzalez, J. da Cuna, E. Andrenelli, M. Fiorio, M. Tinazzi, F. Morgante, A. Fotopoulou, MJ. Edwards, B. Demartini, L. Ricciardi (Milan, Italy)

    Objective: To investigate decision-making abilities of patients with Functional Motor Disorders (FMD) using the Iowa Gambling Task (IGT). Background: FMD is a heterogeneous neuropsychiatric condition…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley